Drug take-overs reflect changing industry

Ownership, Board Characteristics and Non-hostile Take-overs in the Uk: an Empirical and Predictive Analysis

This paper analyses the corporate governance mechanisms of a sample of companies that have been acquired by friendly take-over and those of a matching control sample that have not. It also uses a holdout sample to assess the model’s ability to correctly classify take-over candidates. The results show that the targets were poor performers and that there are significant governance differences bet...

Changing the topic: how long does it take?

We examine the frequency of topic change in Australian court dialogue with a view to automatically changing language models.

Managed care and a changing pharmaceutical industry.

Pumps and Their Systems—a Changing Industry

consultant and is the Senior Member of the consulting firm, Robert J. Hart Enterprises, LLC. He was previously employed by the Dupont Company (27 years) and retired as a Principal Consultant in the Rotating Machinery Group in the Engineering Department. His primary responsibilities were to define Corporate pumping system philosophy and procedures, provide technical guidance on special pumping a...

The changing structure of the pharmaceutical industry.

Rising research and development (R&D) expenditures by pharmaceutical companies are, in part, a consequence of changing industry structure, particularly the rise of the biotechnology sector. The creation of a market for biomedical science and increased vertical competition within the industry are likely to spur innovation and raise productivity, but they also could induce socially wasteful spend...